Catalog No.:AA00DGQ5

463930-25-8 | BAY 55-9837

Name: Name:BAY 55-9837
Brand: AABLOCKS
SKU: AA00DGQ5
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

1mg

99%

1 week

$606.00 $424.00

- +

5mg

99%

1 week

$1,558.00 $1,091.00

- +

10mg

99%

1 week

$2,511.00 $1,758.00

- +

Technical Information
Properties
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Literature

Technical Information

Catalog Number:

AA00DGQ5

Chemical Name:

BAY 55-9837

CAS Number:

463930-25-8

Molecular Formula:

C167H270N52O46

Molecular Weight:

3742.2515

MDL Number:

MFCD10566711

SMILES:

NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CCCCN)CC(=O)N)CCCCN)[C@H](CC)C)CO)CCC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C)C)C(C)C)CCC(=O)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N

Properties

Computed Properties

Complexity:

8680

Covalently-Bonded Unit Count:

Defined Atom Stereocenter Count:

Heavy Atom Count:

265

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Rotatable Bond Count:

132

XLogP3:

-16.7

Literature

Title: Anti-hyperglycemic, antioxidant and anti-inflammatory effects of VIP and a VPAC1 agonist on streptozotocin-induced diabetic mice.

Journal: Peptides 20110201

Title: Effects of VPAC2 receptor activation on membrane excitability and GABAergic transmission in subparaventricular zone neurons targeted by suprachiasmatic nucleus.

Journal: Journal of neurophysiology 20090901

Title: Involvement of VPAC1 and VPAC2 receptors in increasing local pancreatic blood flow in anesthetized rats.

Journal: Pancreas 20080801

Title: A novel recombinant, VPAC2-selective agonist enhancing insulin release and glucose disposal.

Journal: Acta pharmacologica Sinica 20070401

Title: Engineering novel VPAC2-selective agonists with improved stability and glucose-lowering activity in vivo.

Journal: The Journal of pharmacology and experimental therapeutics 20070201

Title: Distribution of the VPAC2 receptor in peripheral tissues of the mouse.

Journal: Endocrinology 20040301

Title: A potent and highly selective VPAC2 agonist enhances glucose-induced insulin release and glucose disposal: a potential therapy for type 2 diabetes.

Journal: Diabetes 20020501

Title: Tsutsumi M, et, al. A potent and highly selective VPAC2 agonist enhances glucose-induced insulin release and glucose disposal: a potential therapy for type 2 diabetes. Diabetes. 2002 May; 51(5): 1453-60.

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country: